LinkedIn Profile

Access Amneal Pharmaceuticals historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nyse:amrx 137969 May 5th, 2024 12:00AM Amneal Pharmaceuticals 160K 5226 Open May 5th, 2024 03:46AM May 5th, 2024 03:46AM Amneal (NASDAQ: AMRX) is rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Our family delivers for yours through a robust U.S. generics business, a growing branded business and deepening portfolios in injectables, biosimilars and select international markets. We’ve bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. And we invest substantially in our people through leadership development and employee well-being programs – all so we can deliver even more value. We are Amneal and We make healthy possible. Content is for informational purposes only and 3rd party content does not reflect Amneal’s opinions. Amneal has the right to remove comments that violate another’s copyright or intellectual property, mention an Amneal product, use profanity or are defamatory, promote and solicit for third-party sites, initiatives, or products, or are factually inaccurate or misleading or spam. Amneal recommends that you consult with your healthcare provider regarding personal health matters. To report a product complaint or adverse event related to an Amneal product, contact Drug Safety at 877-835-5472, option 3 or drugsafety@amneal.com. If you are currently experiencing a life-threatening event, please immediately contact 911. Open Open 400 Crossing Boulevard Bridgewater New Jersey US 08807 Amneal Pharmaceuticals
nyse:amrx 33911 May 5th, 2024 12:00AM Impax Laboratories 9.5K 376.00 Open May 5th, 2024 03:46AM May 5th, 2024 03:46AM Impax combined with Amneal Pharmaceuticals LLC to form a dynamic combined company, Amneal Pharmaceuticals, Inc. (NYSE:AMRX), powered by a robust U.S. generics business and growing branded franchise. Together, we are harnessing our strengths to bring new ideas to the healthcare environment. We are uniting people, passion and products to deliver outcomes that meet important medical needs, make quality medicines more accessible and more affordable, and provide solutions for tomorrow’s health challenges. Learn more about our combination with Amneal and how we’re making a difference in generics, brands and biosimilars at www.Amneal.com or www.ImpaxLabs.com. Open Controlled-release and solid oral-dose pharmaceuticals Open 30831 Huntwood Avenue Hayward CA US 94544 Amneal Pharmaceuticals
nyse:amrx 137969 May 4th, 2024 12:00AM Amneal Pharmaceuticals 160K 5226 Open May 4th, 2024 12:00AM May 4th, 2024 07:39PM Amneal (NASDAQ: AMRX) is rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Our family delivers for yours through a robust U.S. generics business, a growing branded business and deepening portfolios in injectables, biosimilars and select international markets. We’ve bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. And we invest substantially in our people through leadership development and employee well-being programs – all so we can deliver even more value. We are Amneal and We make healthy possible. Content is for informational purposes only and 3rd party content does not reflect Amneal’s opinions. Amneal has the right to remove comments that violate another’s copyright or intellectual property, mention an Amneal product, use profanity or are defamatory, promote and solicit for third-party sites, initiatives, or products, or are factually inaccurate or misleading or spam. Amneal recommends that you consult with your healthcare provider regarding personal health matters. To report a product complaint or adverse event related to an Amneal product, contact Drug Safety at 877-835-5472, option 3 or drugsafety@amneal.com. If you are currently experiencing a life-threatening event, please immediately contact 911. Open Open 400 Crossing Boulevard Bridgewater New Jersey US 08807 Amneal Pharmaceuticals
nyse:amrx 33911 May 4th, 2024 12:00AM Impax Laboratories 9.5K 376.00 Open May 4th, 2024 12:00AM May 4th, 2024 07:39PM Impax combined with Amneal Pharmaceuticals LLC to form a dynamic combined company, Amneal Pharmaceuticals, Inc. (NYSE:AMRX), powered by a robust U.S. generics business and growing branded franchise. Together, we are harnessing our strengths to bring new ideas to the healthcare environment. We are uniting people, passion and products to deliver outcomes that meet important medical needs, make quality medicines more accessible and more affordable, and provide solutions for tomorrow’s health challenges. Learn more about our combination with Amneal and how we’re making a difference in generics, brands and biosimilars at www.Amneal.com or www.ImpaxLabs.com. Open Controlled-release and solid oral-dose pharmaceuticals Open 30831 Huntwood Avenue Hayward CA US 94544 Amneal Pharmaceuticals
nyse:amrx 137969 May 3rd, 2024 12:00AM Amneal Pharmaceuticals 160K 5222 Open May 2nd, 2024 11:57PM May 3rd, 2024 03:26PM Amneal (NASDAQ: AMRX) is rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Our family delivers for yours through a robust U.S. generics business, a growing branded business and deepening portfolios in injectables, biosimilars and select international markets. We’ve bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. And we invest substantially in our people through leadership development and employee well-being programs – all so we can deliver even more value. We are Amneal and We make healthy possible. Content is for informational purposes only and 3rd party content does not reflect Amneal’s opinions. Amneal has the right to remove comments that violate another’s copyright or intellectual property, mention an Amneal product, use profanity or are defamatory, promote and solicit for third-party sites, initiatives, or products, or are factually inaccurate or misleading or spam. Amneal recommends that you consult with your healthcare provider regarding personal health matters. To report a product complaint or adverse event related to an Amneal product, contact Drug Safety at 877-835-5472, option 3 or drugsafety@amneal.com. If you are currently experiencing a life-threatening event, please immediately contact 911. Open Open 400 Crossing Boulevard Bridgewater New Jersey US 08807 Amneal Pharmaceuticals
nyse:amrx 33911 May 3rd, 2024 12:00AM Impax Laboratories 9.5K 376.00 Open May 2nd, 2024 11:57PM May 3rd, 2024 03:26PM Impax combined with Amneal Pharmaceuticals LLC to form a dynamic combined company, Amneal Pharmaceuticals, Inc. (NYSE:AMRX), powered by a robust U.S. generics business and growing branded franchise. Together, we are harnessing our strengths to bring new ideas to the healthcare environment. We are uniting people, passion and products to deliver outcomes that meet important medical needs, make quality medicines more accessible and more affordable, and provide solutions for tomorrow’s health challenges. Learn more about our combination with Amneal and how we’re making a difference in generics, brands and biosimilars at www.Amneal.com or www.ImpaxLabs.com. Open Controlled-release and solid oral-dose pharmaceuticals Open 30831 Huntwood Avenue Hayward CA US 94544 Amneal Pharmaceuticals
nyse:amrx 33911 May 2nd, 2024 12:00AM Impax Laboratories 9.5K 376.00 Open May 2nd, 2024 12:05AM May 2nd, 2024 11:06AM Impax combined with Amneal Pharmaceuticals LLC to form a dynamic combined company, Amneal Pharmaceuticals, Inc. (NYSE:AMRX), powered by a robust U.S. generics business and growing branded franchise. Together, we are harnessing our strengths to bring new ideas to the healthcare environment. We are uniting people, passion and products to deliver outcomes that meet important medical needs, make quality medicines more accessible and more affordable, and provide solutions for tomorrow’s health challenges. Learn more about our combination with Amneal and how we’re making a difference in generics, brands and biosimilars at www.Amneal.com or www.ImpaxLabs.com. Open Controlled-release and solid oral-dose pharmaceuticals Open 30831 Huntwood Avenue Hayward CA US 94544 Amneal Pharmaceuticals
nyse:amrx 137969 May 2nd, 2024 12:00AM Amneal Pharmaceuticals 160K 5222 Open May 2nd, 2024 12:05AM May 2nd, 2024 11:06AM Amneal (NASDAQ: AMRX) is rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Our family delivers for yours through a robust U.S. generics business, a growing branded business and deepening portfolios in injectables, biosimilars and select international markets. We’ve bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. And we invest substantially in our people through leadership development and employee well-being programs – all so we can deliver even more value. We are Amneal and We make healthy possible. Content is for informational purposes only and 3rd party content does not reflect Amneal’s opinions. Amneal has the right to remove comments that violate another’s copyright or intellectual property, mention an Amneal product, use profanity or are defamatory, promote and solicit for third-party sites, initiatives, or products, or are factually inaccurate or misleading or spam. Amneal recommends that you consult with your healthcare provider regarding personal health matters. To report a product complaint or adverse event related to an Amneal product, contact Drug Safety at 877-835-5472, option 3 or drugsafety@amneal.com. If you are currently experiencing a life-threatening event, please immediately contact 911. Open Open 400 Crossing Boulevard Bridgewater New Jersey US 08807 Amneal Pharmaceuticals
nyse:amrx 137969 May 1st, 2024 12:00AM Amneal Pharmaceuticals 160K 5225 Open May 1st, 2024 01:55AM May 1st, 2024 10:29AM Amneal (NASDAQ: AMRX) is rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Our family delivers for yours through a robust U.S. generics business, a growing branded business and deepening portfolios in injectables, biosimilars and select international markets. We’ve bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. And we invest substantially in our people through leadership development and employee well-being programs – all so we can deliver even more value. We are Amneal and We make healthy possible. Content is for informational purposes only and 3rd party content does not reflect Amneal’s opinions. Amneal has the right to remove comments that violate another’s copyright or intellectual property, mention an Amneal product, use profanity or are defamatory, promote and solicit for third-party sites, initiatives, or products, or are factually inaccurate or misleading or spam. Amneal recommends that you consult with your healthcare provider regarding personal health matters. To report a product complaint or adverse event related to an Amneal product, contact Drug Safety at 877-835-5472, option 3 or drugsafety@amneal.com. If you are currently experiencing a life-threatening event, please immediately contact 911. Open Open 400 Crossing Boulevard Bridgewater New Jersey US 08807 Amneal Pharmaceuticals
nyse:amrx 33911 May 1st, 2024 12:00AM Impax Laboratories 9.5K 376.00 Open May 1st, 2024 01:55AM May 1st, 2024 10:29AM Impax combined with Amneal Pharmaceuticals LLC to form a dynamic combined company, Amneal Pharmaceuticals, Inc. (NYSE:AMRX), powered by a robust U.S. generics business and growing branded franchise. Together, we are harnessing our strengths to bring new ideas to the healthcare environment. We are uniting people, passion and products to deliver outcomes that meet important medical needs, make quality medicines more accessible and more affordable, and provide solutions for tomorrow’s health challenges. Learn more about our combination with Amneal and how we’re making a difference in generics, brands and biosimilars at www.Amneal.com or www.ImpaxLabs.com. Open Controlled-release and solid oral-dose pharmaceuticals Open 30831 Huntwood Avenue Hayward CA US 94544 Amneal Pharmaceuticals

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.